Dear FierceBioResearcher Subscriber,
Do you know a high quality start-up biotech company pursuing the discovery of life-saving medicines?
Biotechnology Value Fund, L.P., a San Francisco-based investment group founded in 1993, is expanding its early-stage investment activities and seeks new opportunities. We are reaching out to subscribers of FierceBioResearcher for referrals to exceptional new companies.
We are not a traditional venture firm. For one, our goal is to combine investor returns with positive social impact. To this end, we are only interested in opportunities which possess both of these traits.
Specifically, we seek discovery-oriented, preclinical therapeutics companies founded by senior scientists with excellent research credentials. We are not interested in devices, services, or diagnostics. Typically, the entity will already have been incorporated and will have licensed the founding scientist's technology (or have an option to license contingent on funding). The company may have raised some angel money, but usually no substantial institutional money. We are looking to invest up to a few million dollars to start, with the ability to invest substantially more over time.
If appropriate, please feel free to forward this letter on to your colleagues or acquaintances. If we do invest in a company based on an introduction, we would be pleased to consider providing a mutually agreeable incentive to the referring parties.
I appreciate your time and attention.
Sincerely,
Adam Bristol, Ph.D.
Biotechnology Value Fund, L.P.
1 Sansome St., 39th Fl.
San Francisco, CA 94115
Email: Bristol@BVFlp.com
Phone: 415-288-2399